Common Contracts
18 similar Securities Purchase Agreement contracts by Infinity Energy Resources, Inc, Advaxis, Inc., AppTech Payments Corp., others
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 30th, 2024 • Ensysce Biosciences, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of August 28, 2024, between Ensysce Biosciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 26th, 2024 • MultiSensor AI Holdings, Inc. • Optical instruments & lenses • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June [__], 2024 (the “Subscription Date”), between MultiSensor AI Holdings, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 31st, 2023 • AppTech Payments Corp. • Services-prepackaged software • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of January 30, 2023 between AppTech Payments Corp., a Delaware corporation with headquarters located at 5876 Owens Ave. Suite 100, Carlsbad, California 92008 (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 18th, 2022 • First Wave BioPharma, Inc. • Pharmaceutical preparations • Delaware
This Securities Purchase Agreement (this “Agreement”) is dated as of July 15, 2022, between First Wave BioPharma, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 8th, 2022 • Polarityte, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 5, 2022, between PolarityTE, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 18th, 2022 • Troika Media Group, Inc. • Cable & other pay television services • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of March 16, 2022, between Troika Media Group, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 30th, 2021 • Bit Digital, Inc • Finance services • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September 29, 2021, between Bit Digital, Inc., a Cayman Islands corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 22nd, 2021 • Infinity Energy Resources, Inc • Drilling oil & gas wells • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March 16, 2021, is by and among Infinity Energy Resources, Inc., a Delaware corporation with headquarters located at 11900 College Blvd., Suite 310, Overland Park, KS 66210 (the “Company”), and the investors who are signatories to this Agreement (each, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 12th, 2021 • Advaxis, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of April 12, 2021 between Advaxis, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 30th, 2021 • Infinity Energy Resources, Inc • Drilling oil & gas wells • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March 16, 2021, is by and among Infinity Energy Resources, Inc., a Delaware corporation with headquarters located at 11900 College Blvd., Suite 310, Overland Park, KS 66210 (the “Company”), and the investors who are signatories to this Agreement (each, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 11th, 2021 • Enveric Biosciences, Inc. • Semiconductors & related devices • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of February 9, 2021, between Enveric Biosciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 19th, 2019 • ReShape Lifesciences Inc. • Electromedical & electrotherapeutic apparatus • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 13, 2019, between ReShape Lifesciences Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 7th, 2019 • Innovus Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 30, 2018, between Innovus Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 14th, 2018 • OncBioMune Pharmaceuticals, Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September 24, 2018, between OncBioMune Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 20th, 2017 • Interpace Diagnostics Group, Inc. • Surgical & medical instruments & apparatus • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of January 20, 2017, between Interpace Diagnostics Group, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 12th, 2016 • Sysorex Global • Services-computer programming services • New York
Pursuant to (i) the acquisition of Lilien Systems completed on March 20, 2013; (ii) the acquisition of Shoom completed on September 6, 2013; (iii) the acquisition of AirPatrol completed on April 16, 2014; (iv) the Registration Rights Agreements dated March 15, 2013 and August 29, 2013, under which Sysorex Global (“Sysorex”) agreed to register 83,334 and 56,250 shares of common stock, respectively, underlying warrants issued to Bridge Bank, N.A., n/k/a Western Alliance Bank, in connection with credit facilities; and (v) the sale of 400,000 shares of common stock to Geneseo Communications, Inc. on February 24, 2014, under which Sysorex agreed to grant piggy-back registration rights for such shares, Sysorex registered 166,667 shares for Geoffrey Lilien under the S-1 registration statement that was declared effective by the SEC on April 8, 2014 and a total of 5,768,470 shares of common stock including 139,584 shares underlying the warrants, under the S-1 registration statement that was dec
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 4th, 2015 • InspireMD, Inc. • Surgical & medical instruments & apparatus • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of March 4, 2015, between InspireMD, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 14th, 2008 • Patient Safety Technologies, Inc • Orthopedic, prosthetic & surgical appliances & supplies • California
This Securities Purchase Agreement (this “Agreement”) is dated as of August 1, 2008 by and between Patient Safety Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).